Advances in Drug Delivery Systems and Therapies for Ocular Disorders
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 4341
Special Issue Editor
Interests: nanotechnology; controlled drug delivery; magnetic nanoparticles; cancer therapy; biomaterials; tissue engineering
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, the number of patients with ocular diseases is increasing as a consequence of population aging. In 2020, 1 billion people suffered from vision impairment, and this figure is expected to increase to 1.8 billion people by 2050. The most common causes of ocular disorders are cataract, glaucoma, age-related macular degeneration, diabetic retinopathy, and presbyopia.
This Special Issue is focused on different disorders and pathogenesis occurring in the eye and their possible therapies for treatment. The main goal is to show the current status and future perspectives of different treatment approaches, from the use of artificial or natural biomaterials (ocular tissue engineering) to emerging ocular sustained drug delivery treatments (clinical trials).
Prof. Dr. Felisa Reyes-Ortega
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.